johnson-chief
J&J makes takeover approach for Swiss drugmaker Actelion: Bloomberg
November 25, 2016 by creative · Leave a Comment
(Reuters) – U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday, citing people it said were familiar with the matter. The report said that deliberations are still at an early stage following Johnson & Johnson's initial offer, and Actelion is working with an adviser to explore options. Johnson & Johnson Chief Executive Alex Gorsky said earlier this year that the company
Here is the original:
J&J makes takeover approach for Swiss drugmaker Actelion: Bloomberg